Skip to main content

Table 2 Effect of zosuquidar on mitoxantrone accumulation in K562/BCRP and K562/Vec cells

From: Zosuquidar restores drug sensitivity in P-glycoprotein expressing acute myeloid leukemia (AML)

 

FTC (10 μM)

Zosuquida

K562/Vec

0

0

K562/BCRP

0.59 ± 0.11

0.04 ± 0.07